Advertisement
Advertisement

PRCT

PRCT logo

PROCEPT BioRobotics Corporation Common Stock

19.15
USD
Sponsored
-0.16
-0.83%
Jul 15, 16:00 UTC -4
Closed
exchange

After-Market

19.11

-0.04
-0.23%

PROCEPT BioRobotics Corporation Common Stock Profile

About

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif.

Info & Links

CEO

Larry Wood

Headquarters

150 Baytech Drive
San Jose, CA 95134, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.procept-biorobotics.com

Auditor

PricewaterhouseCoopers LLP

Share holders

--

Employees

888

PROCEPT BioRobotics Corporation Common Stock Statistics

Valuation Measures

Market Capitalization2

1.09B

Enterprise Value

893.46M

Enterprise Value/EBITDA(ttm)

-8.73

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.26

Price to Book(mrq)

3.55

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

63.66%

Operating Margin(ttm)

-31.02%

Profit Margin(ttm)

-31.32%

Return on Equity(ttm)

-25.13%

Return on Invested Capital(ttm)

-22.20%

Return on Assets(ttm)

-18.63%

Income Statement

Revenue(ttm)

322.02M

Revenue Per Share(ttm)

5.66

Gross Profit(ttm)

206.01M

EBITDA(ttm)3

-102.38M

Net Income Available to Common(ttm)

-102.47M

Diluted EPS(ttm)

-1.71

Share Statistics

Beta (5Y Monthly)

0.94

52-Week Change

-67.08%

S&P 500 52-Week Change

20.89%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

56.92M

Dividend Yield

0.00%

Float4

52.67M

% Held by Insiders

6.60%

% Held by Institutions

89.46%

Balance Sheet

Total Cash(mrq)

245.64M

Total Cash Per Share(mrq)

4.32

Total Debt(mrq)

51.66M

Total Debt/Equity(mrq)

14.11%

Current Ratio(mrq)

6.85%

Quick Ratio(mrq)

5.77%

Book Value Per Share(mrq)

6.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.88

Free Cash Flow(ytd)

-58.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement